A detailed molecular investigation of HLA-G and its regulation in an in vitro breast cancer or malignant melanoma setting will contribute to the search of mechanisms that can be exploited to therapeutically target HLA-G-mediated immune suppression in cancer. The gene discussed is HLA-G; the disease is breast cancer.